SAVE Act of 2023

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.

Client expense: Not reported · Firm income: $10,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240 CR - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 H.R. 10545, the American Relief Act, 2025

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid crisis legislation, naloxone access and awareness. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240. H.R. 10445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025. H.R. 10545, the American Relief Act, 2025.

Client expense: $650,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Asking Congress to cosponsor H.R. 2474, the Strengthening Medicare for Patients and Providers Act, which would align Medicare physician payments with other sectors of Medicare by adding a mandatory annual inflation update. To also cosponsor H.R. 6371, the Provider Reimbursement Stability Act, which would increase the budget-neutrality threshold, set limits on conversion factor variance, and allow CMS to enhance accountability and stability within the physician payment system. Support H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.

Client expense: Not reported · Firm income: $10,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25. Naloxone access and awareness legislation. State opioid response (SOR) Grant funding for FY25. Substance Abuse and Mental Health Block Grant (SABG) funding and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $500,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; FAA reauthorization - increasing access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948; School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946; Protecting Kids from Fentanyl Act of 2023 - H.R. 4582; Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $50,000

H.R. 5625, the Fentanyl Awareness for Children and Teens in Schools (FACTS) Act, which would help to address the opioid crisis by making naloxone available in school settings. Support H.R. 5420 / S. 2948, the Workplace Overdose Reversal Kits (WORK) to Save Lives Act which would require opioid overdose reversal medications to be in federal buildings and create non-mandatory guidance for private employers on how to obtain these medications; both important measures to reduce opioid overdose fatalities. Support H.R. 6161, the Supporting Access to Vital and Affordable Care for Everyone (SAVE) Act, which would make access to over-the-counter naloxone more affordable by ensuring it qualifies as a deductible medical expense.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, Veterans Affairs, Dept of (VA)

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948. School Access to Naloxone Act of 2023 - H.R.3065, S.2946. Protecting Kids from Fentanyl Act of 2023 - H.R.4582. Saving Lives in Schools Act of 2023 - H.R.4240.

Client expense: $460,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 and FY25 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948

Client expense: Not reported · Firm income: $50,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25; Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines; State opioid response (SOR) Grant funding for FY24 and FY25; Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25; NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone; HANDS Act - H.R. 5506; SAVE Act of 2023 - H.R. 6161; Overdose Reversal Medication (ORM) Act - H.R. 6243; Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948.

Client expense: Not reported · Firm income: $45,000

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.

Client expense: $760,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.

Client expense: $760,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.

Client expense: $760,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act. Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 and FY25. Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines. State opioid response (SOR) Grant funding for FY24 and FY25. Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 and FY25. NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone. FAA reauthorization - increasing access to naloxone. HANDS Act - H.R.5506. SAVE Act of 2023 - H.R.6161. Overdose Reversal Medication (ORM) Act - H.R.6243. Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R.5420, S.2948.

Client expense: $760,000 · Firm income: Not reported

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY24 Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines State opioid response (SOR) Grant funding for FY24 Substance Abuse and Mental Health Block Grant (SABG) funding for FY24 NDAA for Fiscal Year 2024 - provisions related to biological and chemical defense and access to naloxone FAA reauthorization - increasing access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE